Detiphar SRL
1.0 FTEDetiphar reported total assets of 356,249 € at the end of the 2025 financial year (annual accounts filed with the NBB on 03 Jul 2026), with 1 full-time equivalent.
The score of Detiphar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +9 % Total assets -18 % Headcount (avg FTE) -47 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Detiphar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −2,602 € | ||||
| Equity | 236,807 € | ||||
| Cash | 83,582 € | ||||
| EBITDA | 11,201 € | ||||
| Total assets | 356,249 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Jul 2026
- Year ended 31 Dec 2024filed on 16 Jul 2025
- Year ended 31 Dec 2023filed on 25 Jul 2024
- Year ended 31 Dec 2022filed on 20 Jul 2023
- Year ended 31 Dec 2021filed on 22 Jul 2022
Detiphar's financial analysis
- Solvency66.5%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Detiphar
Detiphar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0829.842.621
- VAT number
- BE0829842621
- Peppol
- Registered · 0208:0829842621 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Sep 2010
- Registered office
- 7340 Colfontaine
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 03 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Detiphar (SRL) has been based in Colfontaine since 2010, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 2,602 € and equity of 236,807 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 66.5%, above the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Detiphar
Companies in the same business, of comparable size and area, outside its group.
- Pharma DMS Retail sale of pharmaceutical products Roeselare · balance sheet 355,287 €
- Pharmabak Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 357,515 €
- Apotheek Dampoort Retail sale of pharmaceutical products Bruges · balance sheet 357,644 €
- Apoteek Hancour Retail sale of pharmaceutical products Anderlecht · balance sheet 354,659 €
- Pharmacie Lonneux Retail sale of pharmaceutical products Liège · balance sheet 358,360 €
- Groot Zand Retail sale of pharmaceutical products Dendermonde · balance sheet 358,515 €
- Société Pharmaceutique belge Retail sale of pharmaceutical products Saint-Gilles · balance sheet 358,883 €
- Brupharma Retail sale of pharmaceutical products Bruges · balance sheet 360,003 €
Frequently asked questions about Detiphar
What is the revenue of Detiphar?
Detiphar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Detiphar?
In Belgium, the VAT number is the company number prefixed with BE: BE0829842621 for Detiphar, if the company is VAT-registered. Its company number (CBE) is 0829.842.621.
Where is the registered office of Detiphar?
According to the CBE register, the registered office of Detiphar is in 7340 Colfontaine.
What is the equity of Detiphar?
At the close of the 2025 financial year, the equity of Detiphar amounts to 236,807 €, a solvency of 66.5% of total assets.
How many people work at Detiphar?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Detiphar?
The register lists 2 active mandates at Detiphar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Detiphar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →